Chronic Periodontitis Clinical Trial
Official title:
Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis
Periodontitis are inflammatory diseases characterized by the destruction of the tooth-supporting bone due to increased bone resorption by osteoclasts (OCLs). Two forms are described: chronic periodontitis (CP) and aggressive periodontitis (AP) that differ by the severity and rapidity of bone loss, much more important for AP than CP. In both forms, the link with uncontrolled activation of the immune system is largely admitted. Despite the physiopathology of CP is fairly well studied, very few data are available regarding AP. The investigators aim is to understand the severity of AP by analyzing the proportion and action of immune and mesnchymal cells potentially involved in bone destruction, on biopsies of periodontal granulation tissue (surgical waste) and blood. Three groups of 20 patients will be included: affected with AP, CP or controls (necessitating an extraction of wisdom teeth).
Context: Periodontitis are inflammatory diseases affecting the periodontium and characterized
by the destruction of the tooth-supporting bone due to increased bone resorption by
osteoclasts (OCLs). Two forms are described: chronic periodontitis (CP) and aggressive
periodontitis (AP) that differ by the severity and rapidity of bone loss, much more important
for AP than CP. In both forms, the link with uncontrolled activation of the immune system is
largely admitted. But despite the physiopathology of CP is fairly well studied, very few data
are available regarding AP. Based on the investigators previous studies, their hypothesis to
explain this severity is the existence of a vicious circle involving immune cells,
mesenchymal cells and OCLs, that would maintain and amplify inflammation and bone loss.
Study: this is a transversal, interventional and single-center study. It includes 3 groups of
20 patients: affected with AP, CP or controls (necessitating an extraction of wisdom teeth).
Aims: the investigators will compare the proportion of immune and mesenchymal cells in the 3
groups of patients to identify the populations potentially involved in bone destruction. The
investigators will compare in vitro their capacity to induce OCL differentiation in order to
determine their role in bone loss. The investigators will also compare the capacity of OCLs
and mesenchymal cells to activate T cells, in order to determine their role in inflammation.
Methodology: patients will be recruited in the department of periodontology, CHU of Nice.
After signing the informed consent, a biopsy of periodontal granulation tissue (surgical
waste) will be collected during the usual treatment of these diseases, as well as a blood
sample. Then, patients will leave the study. Cells from the biopsies will be analyzed by flow
cytometry to determine the proportion of lymphocytic, monocytic and mesenchymal cells. In
vitro, their capacity to induce OCL differentiation or to activate T cells will be
determined. From the blood samples, OCLs will be generated to study their capacity to
activate T cells.
Chronology of consultations and examinations: 3 visits are planned: (1) a routine visit
corresponding to the usual treatment of the patient during which it is proposed to
participate in the study, (2) a visit to obtaining consent, clinical examination, criteria
verification and (3) a visit corresponding to the usual treatment in which will be collected
tissue biopsies and blood.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06400069 -
Role of NLRP6 in Chronic Periodontitis
|
||
Completed |
NCT05231096 -
Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis
|
N/A | |
Completed |
NCT03203746 -
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03354338 -
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
|
Phase 2 | |
Completed |
NCT02516111 -
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
|
Phase 2/Phase 3 | |
Terminated |
NCT02568163 -
Influence of Stress on Non Surgical Periodontal Treatment
|
N/A | |
Completed |
NCT02174146 -
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
|
N/A | |
Completed |
NCT02430519 -
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
|
N/A | |
Completed |
NCT01438333 -
Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection
|
N/A | |
Completed |
NCT01233765 -
Analysis of Neutrophil Response in Chronic Periodontitis
|
N/A | |
Completed |
NCT02218515 -
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
|
Phase 4 | |
Completed |
NCT02197260 -
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
|
Phase 4 | |
Not yet recruiting |
NCT03270280 -
Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis
|
Phase 2 | |
Not yet recruiting |
NCT04026828 -
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
|
||
Completed |
NCT04697199 -
The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis
|
Phase 1 | |
Completed |
NCT04643288 -
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
|
N/A | |
Completed |
NCT03039244 -
Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers
|
N/A | |
Completed |
NCT02898675 -
Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing
|
N/A | |
Completed |
NCT03874390 -
Effects of Ozone Therapy on Clinical Parameters and Inflammatory Cytokines in Chronic Periodontitis Patients
|
N/A | |
Completed |
NCT02518152 -
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
|
Phase 2/Phase 3 |